Lauren's practice focuses on advising clients through complex health care transactions and regulatory matters. She has served as health care counsel on numerous private equity and strategic transactions, including mergers and acquisitions, joint ventures, affiliations, and investments involving pharmacies, PBMs, physician practices, long-term care facilities, third party payors, value-based contracting entities, nurse staffing companies, and health care technology firms.
Lauren’s deal work is complimented by her regulatory practice, which primarily focuses on advising pharmacies, PBMs, managed care organizations and other clients in the payor space. Drawing from her experience working for the Federal Coordinated Health Care Office (the “Duals Office”) within the Centers for Medicare & Medicaid Services (“CMS”), she is able to provide practical advice to clients on regulatory and compliance issues relating to Medicare Advantage, Medicare Part D and Medicaid. She has advised clients on Medicare Advantage and Medicare Part D applications, audit appeals, contract negotiations, Medicaid managed care RFPs, and payment issues.
Lauren’s regulatory practice also focuses on compliance with the anti-kickback statute, corporate practice of medicine and fee-splitting prohibitions, telemedicine, and prescribing and licensing requirements (including change of ownership requirements).
Prior to her tenure with CMS, she was a research consultant with a health care consulting company in the DC area, working primarily with state Medicaid agencies and Medicaid managed care plans.
Experience
- Counseled private equity sponsors on health care acquisitions, including fraud and abuse issues, licensure, change of ownership, and payor matters.
- Served as health care regulatory counsel to several banks and lenders in debt financing transactions, including advising on the impact of corporate practice of medicine and other health care regulatory matters on the credit agreement and accompanying deal documents.
- Provided health care regulatory counsel to Cornell Capital in its acquisitions of truestaff and CardioSolution, as well as the acquisitions of various nurse staffing companies by Ingenovis Health.
- Advised national pharmacy chain in multiple specialty pharmacy and long-term care pharmacy acquisitions.
- Advised venture capital and private equity firms on Series C and minority investments in various health care technology firms and value-based contracting entities.
- Represented Sanford Health, a non-profit integrated health delivery system, in its affiliation with The Evangelical Lutheran Good Samaritan Society (the “Society”), a non-profit long-term care provider. Our representation primarily focused on assisting Sanford in navigating the change of ownership filings for the Society’s licenses and Medicare and Medicaid filings.
- Conducted the due diligence and provided state and federal regulatory research and analysis in connection with TPG’s acquisition of Convey Health Solutions, a specialized health care technology company that provides health plan administration, supplemental benefits administration, and consulting services to health plans.
- Advised a global health care company on a variety of issues in connection with its acquisition of several health plans and provider groups, including health care regulatory due diligence, health care regulatory advice regarding transaction structure and strategy, and preparation of regulatory notices and other filings.
- Served as regulatory counsel to a consortium of investors led by TPG Capital and Welsh, Carson, Anderson & Stowe in their $4.1 billion acquisition of Kindred Healthcare, Inc. (NYSE:KND). The transaction was recognized by The Deal as the 2018 Private Equity Deal of the Year.
- Advised a consortium of investors led by TPG Capital and Welsh, Carson, Anderson & Stowe in their $1.4 billion acquisition of Curo Health Services.
viewpoints
As CMS Lifts HHA Medicare Provider Enrollment Moratorium, States Continue to Limit HHA Licenses
February 12, 2019 | Blog | By Lauren Moldawer
Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads
October 17, 2018 | Blog | By Lauren Moldawer, Theresa Carnegie
The OIG Identifies “Significant Vulnerabilities” in the Medicare Hospice Program: What This Might Mean for Hospice Providers?
August 9, 2018 | Blog | By Lauren Moldawer
The Hazards of Prescription Auto-Refill Programs
June 6, 2018 | Blog | By Lauren Moldawer
Proposed Medicare Advantage and Part D Regulations for CY 2019 - CMS Tries to Clarify Any Willing Pharmacy Rules
November 29, 2017 | Blog | By Lauren Moldawer, Tara E. Dwyer
Health Care Weekly Preview from ML Strategies – Week of October 23, 2017
October 24, 2017 | Blog | By Lauren Moldawer
ML Strategies Explores the Evolution of “Repeal and Replace”
September 28, 2017 | Blog | By Lauren Moldawer
Massachusetts Moves Forward with Efforts to Shore up MassHealth
August 24, 2017 | Blog | By Lauren Moldawer
Mintz’s Employment Matters Blog Analyzes Efforts to Shore up MassHealth
May 30, 2017 | Blog | By Lauren Moldawer
Join us for our Upcoming Webinar: Patient Assistance Programs & Government Enforcement: What You Need to Know
April 27, 2017 | Blog | By Lauren Moldawer
News & Press
Mintz Facilitates $3.7 Billion Deal For The Cigna Group
January 31, 2024
Mintz Announces Record Member Growth in 2023
December 22, 2023
4 Pharma Industry Arguments Against CMS Drug Pricing Plan
September 29, 2023
Mintz Advises Kindred at Home in $5.7 Billion Sale to Humana
August 23, 2021
Events & Speaking
Recognition & Awards
Best Lawyers in America: Ones to Watch - Health Care Law (2024)